Skip to Content

TRICCAR Inc TCCR

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

TRICCAR Inc is biomedical research, development, and marketing firm that develops and acquires to bring bioceutical solutions and pharmaceutical drugs to support the well-being of humans and animals having common diseases. Its products include bioceutical formulations designed to support illnesses and diseases, including four formulae built around a patented fruit-based calcium supplement; a weight loss and obesity supplement; a formula that helps relieve the symptoms of menopause; a blood performance product that separates white and red blood cells; a mental focus formula to increase attention and recall of information and beneficial to children diagnosed with Attention Deficit Disorder; a mental acuity formula to increase memory recall and aid in the formation of new memories.

Contact
848 North Rainbow Boulevard, No. 3254
Las Vegas, NV, 89107
T +1 702 330-2430
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jun 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 9